These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8214357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.
    Ohga S, Matsuzaki A, Nishizaki M, Nagashima T, Kai T, Suda M, Ueda K.
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):291-8. PubMed ID: 8328642
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T.
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.
    Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH.
    N Engl J Med; 1988 Aug 18; 319(7):397-400. PubMed ID: 3135497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum interleukin-1 and tumor necrosis factor activities in febrile children with acute leukemia.
    Ishii E, Ohga S, Ueda K, Akazawa K.
    Int J Hematol; 1991 Feb 18; 54(1):79-84. PubMed ID: 1954355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A, Wang JT, Chia JS, Chiang CP.
    J Oral Pathol Med; 2006 Feb 18; 35(2):111-6. PubMed ID: 16430742
    [Abstract] [Full Text] [Related]

  • 13. [Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].
    Matsubara T.
    Arerugi; 1990 Feb 18; 39(2 Pt 1):118-23. PubMed ID: 2112909
    [Abstract] [Full Text] [Related]

  • 14. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
    Elsässer-Beile U, Kölble N, Grussenmeyer T, Wetterauer U, Schultze-Seemann W.
    Anticancer Res; 1998 Feb 18; 18(3B):1883-90. PubMed ID: 9677439
    [Abstract] [Full Text] [Related]

  • 15. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.
    Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ.
    J Infect Dis; 1999 Feb 18; 179 Suppl 1():S188-91. PubMed ID: 9988183
    [Abstract] [Full Text] [Related]

  • 16. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W, Zhang MH, Yu Y, Xu CG.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 18; 28(10):681-4. PubMed ID: 18399174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.